Search

Leave a Message

By providing your contact information to Daniel Choi, your personal information will be processed in accordance with Daniel Choi's Privacy Policy. By checking the box(es) below, you consent to receive communications regarding your real estate inquiries and related marketing and promotional updates in the manner selected by you. For SMS text messages, message frequency varies. Message and data rates may apply. You may opt out of receiving further communications from Daniel Choi at any time. To opt out of receiving SMS text messages, reply STOP to unsubscribe.

Thank you for your message. I'll be in touch with you shortly.

Explore My Properties

How The Biotech Boom Is Shaping South San Francisco Housing

April 16, 2026

If you have been watching South San Francisco housing, one thing is hard to miss: the biotech industry is not just shaping the local economy, it is shaping where and how people live. Whether you are thinking about buying, selling, or holding property here, you are dealing with a market influenced by jobs, transit, new development, and limited housing supply. This guide breaks down what the biotech boom means for South San Francisco housing today and what it could mean for your next move. Let’s dive in.

Why biotech matters in South San Francisco

South San Francisco is widely known as the “birthplace of biotechnology”. According to the city, the local cluster includes more than 250 biotech companies, about 12 million square feet of biotech space, and supports more than 25,000 workers. The city also reports a daytime population of roughly 90,000 workers and visitors, which shows just how much economic activity flows through the area.

That scale matters for housing because jobs create demand. The city says about 3.5 million square feet of biotech space is currently under construction, and the life-science footprint is expected to double between 2019 and 2035. Even with some softness in the lab market, the long-term relationship between employment growth and housing demand remains a major story in South San Francisco.

How biotech jobs affect housing demand

When a city adds high-paying jobs, more people compete for nearby homes. South San Francisco’s own anti-displacement study says the area east of US-101 shifted from heavy industry into a global biotech cluster, and that change has helped drive up rents and home values.

The same study found that from 2012 to 2022, home values and rents rose by more than 80% to about $1.1 million, while median income rose 67.5%. It also notes that nearly 85% of new R&D jobs are held by people who do not live in South San Francisco. In practical terms, that means the buyer and renter pool is not limited to current residents. It includes commuters and relocating professionals who want access to the job base.

Commute access adds more pressure

Housing demand is not only about jobs. It is also about how easy those jobs are to reach. The city says South San Francisco operates a free shuttle system connecting neighborhoods to the east-of-101 life-science cluster, Caltrain, and BART, while the Oyster Point ferry connects directly to Oakland and Alameda.

The city also reports more than $300 million in public improvements, including the Oyster Point Overpass, hook ramps, the ferry terminal, and future Caltrain improvements. Better connections can expand where biotech workers choose to live, but they also make homes near those routes more attractive. That is one reason nearby housing often feels the demand first.

What the for-sale market looks like now

South San Francisco remains an expensive and relatively tight market. According to Redfin’s South San Francisco housing market data, the median sale price was $1.275 million in February 2026, up 1.6% year over year. Homes sold in about 15 days and received two offers on average.

Zillow’s home value data points in the same direction, even though it measures the market differently. Zillow reported an average home value of $1,212,996 as of February 28, 2026, with 38 homes for sale and 22 days to pending. The exact numbers are not directly interchangeable, but the takeaway is clear: inventory is limited, prices are high, and buyers still need to move with purpose.

What this means for buyers

If you are buying in South San Francisco, biotech-driven demand can show up in a few ways:

  • More competition for well-located homes
  • Faster timelines on updated listings
  • Strong interest in condos, townhomes, and single-family homes with commute convenience
  • Less room for hesitation when inventory is low

That does not mean every listing becomes a bidding war. It does mean your strategy should be grounded in current market conditions, not outdated expectations from a slower cycle.

What this means for sellers

If you are selling, the city’s employment base can support buyer demand, especially for homes that appeal to professionals who want access to transit and major job centers. At the same time, pricing still needs to match current comps and condition.

In other words, the biotech story helps support the market, but it does not replace thoughtful pricing, smart preparation, and strong presentation. Buyers are still comparing value closely.

What is happening with rents

Rental demand in South San Francisco also reflects the local job engine. Zillow Rental Manager lists average rent at $3,395, with one-bedrooms at $2,610, two-bedrooms at $3,362, and three-bedrooms at $4,495. Other rental measures cited in local research land in a similar low-to-mid $3,000 range, reinforcing the same trend.

Rents are not just high. They are also difficult for many households to absorb. The city’s anti-displacement analysis says a household needs more than $106,000 annually to afford the median gross rent of $2,650. It also reports that 24% of renter households are severely cost burdened.

Why affordability still matters

High rents can support property values and rental demand, but affordability pressure changes the market too. The city reports that renter median rent rose 60% from 2010 to 2020, while income rose 54%. It also found that 8.4% of renter households are overcrowded.

For renters, that can mean tougher choices around unit size, location, and budget. For landlords and small investors, it means demand may stay strong, but tenant budgets are still a real limit. Underwriting should be practical, not overly optimistic.

Is new housing enough to keep up?

South San Francisco is adding housing, but the scale of need is significant. The city says it must plan for 3,956 new units during the 2023-2031 RHNA cycle, including units across moderate-, low-, and very-low-income categories. It also reports that 818 units are under construction or recently completed, and that more than 1,500 new units have been built since 2015, mostly downtown near the renovated Caltrain station.

The city is also supporting affordable housing through projects including 1051 Mission Road and Linden Avenue funding commitments. A city report identifies 1051 Mission Road as a BRIDGE Housing project with 158 units that are 100% affordable. These projects matter, but they do not fully erase the broader supply-and-demand imbalance.

Development is changing the city

South San Francisco’s growth is not limited to housing. The Oyster Point Specific Plan area outlines a major bayfront mixed-use district with life-science space, recreation and open space, a future hotel site, and public infrastructure. Related city materials describe roughly 2.5 million square feet of office and R&D space across 10 buildings.

That kind of development can support long-term economic activity, city revenue, and local demand for housing. But it also means the housing market will continue to react to both residential construction and commercial expansion over time.

The biotech boom is still real, but more nuanced now

It is important to look at the full picture. While the biotech sector remains a major force in South San Francisco, the lab market is no longer in a straight-line expansion phase. Research cited in the city notes Bay Area life-sciences vacancy at 32.0% in Q2 2025, Peninsula R&D vacancy at 23.6% in Q2 2025, and negative absorption in South San Francisco.

That matters because future demand may be less explosive than it was during the hottest years of the boom. Still, the existing workforce, established company base, and deep infrastructure investment continue to support housing demand today. For most buyers and sellers, the takeaway is balance: expect lasting demand drivers, but avoid assumptions that every segment will accelerate at the same pace.

What to watch if you plan to buy or sell

If you are trying to make a move in South San Francisco, focus on the factors that matter most:

  • Inventory levels: Low supply can increase competition quickly.
  • Transit access: Homes with easier access to Caltrain, BART, shuttle routes, and Oyster Point often stand out.
  • Property type: Condos, townhomes, and updated single-family homes can attract different buyer pools.
  • Pricing discipline: Sellers need current comps, and buyers need a realistic offer strategy.
  • Pipeline changes: New housing and commercial projects can shape future demand and neighborhood momentum.

The biotech boom has helped make South San Francisco one of the Peninsula’s most closely watched housing markets. If you understand how jobs, transit, supply, and affordability interact, you can make a much more confident decision.

If you want help understanding where your home fits in today’s market, or you are planning a purchase in South San Francisco, Daniel Choi can help you build a clear, data-backed strategy with local guidance every step of the way.

FAQs

How does the biotech industry affect South San Francisco home prices?

  • The biotech industry supports a large local job base, which increases demand for nearby housing. City and market data in South San Francisco point to high prices, limited inventory, and continued competition for homes.

Is South San Francisco still a competitive market for buyers?

  • Yes. Recent Redfin data shows homes selling in about 15 days with two offers on average, which suggests buyers still need to act quickly and make informed offers.

Are rents in South San Francisco rising because of biotech jobs?

  • Biotech employment is one of the key demand drivers. Rental data shows average rents in the low-to-mid $3,000 range, while city data shows ongoing affordability pressure for many renter households.

Is South San Francisco building enough housing to meet demand?

  • The city is adding housing and planning for thousands of units during the 2023-2031 RHNA cycle, but current supply still appears limited relative to long-term job-driven demand.

Should South San Francisco sellers price aggressively because of biotech demand?

  • Sellers can benefit from a strong employment base and limited inventory, but pricing should still reflect current comparable sales, property condition, and today’s buyer expectations.

Work With Daniel

Get assistance in determining current property value, crafting a competitive offer, writing and negotiating a contract, and much more. Contact Daniel today.